Samla, Salima M.

HRN: 10-72-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2024
CEFTRIAXONE 1G (VIAL)
08/12/2024
08/19/2024
IV
2g
OD
Typhoid Fever, UTI
Waiting Final Action 
08/14/2024
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
08/14/2024
08/21/2024
PO
5.8ml
OD
Typhoid Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: